Michael S. Weiss

Overview

Michael S. Weiss received an average of $9.3M in compensation at TG Therapeutics from 2011 to 2018, an average of $5.3M at Fortress Biotech from 2014 to 2016,, and an average of $4.3M at Keryx Biopharmaceuticals from 2006 to 2009.

Related executives

We found 20 more executives who work or worked at TG Therapeutics, Fortress Biotech, andKeryx Biopharmaceuticals.

Sean Power

TG Therapeutics

Chief Financial Officer

Gregory Madison

Keryx Biopharmaceuticals

Chief Executive Officer

Christine Carberry

Keryx Biopharmaceuticals

Chief Operating Officer

John Neylan

Keryx Biopharmaceuticals

Chief Medical Officer

Scott Holmes

Keryx Biopharmaceuticals

Chief Financial Officer

Brian Adams

Keryx Biopharmaceuticals

General Counsel

Lindsay Rosenwald

Fortress Biotech

Chief Executive Officer

George Avgerinos

Fortress Biotech

Senior Vice President, Biologics Operation

News

You may also like